| 35 | Good | NO2 | None | None |
| 1 | Good | O3 PPB | None | None |
| 59 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
| 33 | Good | NO2 | None | None |
| 4 | Good | O3 PPB | None | None |
| 60 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
| 38 | Good | NO2 | None | None |
| 2 | Good | O3 PPB | None | None |
| 60 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
| 39 | Good | NO2 | None | None |
| 1 | Good | O3 PPB | None | None |
| 60 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
| 27 | Good | NO2 | None | None |
| 21 | Good | O3 PPB | None | None |
| 60 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |
| 8 | Good | NO2 | None | None |
| 9 | Good | O3 PPB | None | None |
| 59 | Moderate | PMSC | Respiratory symptoms possible in unusually sensitive individuals, possible aggravation of heart or lung disease in people with cardiopulmonary disease and older adults. | People with heart or lung disease, older adults, and children and the groups at most risk. |